Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2008 1
2009 2
2010 4
2011 2
2012 4
2013 10
2014 10
2015 11
2016 18
2017 11
2018 17
2019 16
2020 20
2021 16
2022 14
2023 9

Text availability

Article attribute

Article type

Publication date

Search Results

134 results

Results by year

Filters applied: . Clear all
Page 1
MRI features of demyelinating disease associated with anti-MOG antibodies in adults.
Denève M, Biotti D, Patsoura S, Ferrier M, Meluchova Z, Mahieu L, Heran F, Vignal C, Deschamps R, Gout O, Champfleur NM, Ayrignac X, Dallière CC, Labauge P, Dulau C, Tourdias T, Dumas H, Cognard C, Brassat D, Bonneville F. Denève M, et al. Among authors: ayrignac x. J Neuroradiol. 2019 Sep;46(5):312-318. doi: 10.1016/j.neurad.2019.06.001. Epub 2019 Jun 20. J Neuroradiol. 2019. PMID: 31228536 Review.
A meta-analysis comparing first-line immunosuppressants in neuromyelitis optica.
Giovannelli J, Ciron J, Cohen M, Kim HJ, Kim SH, Stellmann JP, Kleiter I, McCreary M, Greenberg BM, Deschamps R, Audoin B, Maillart E, Papeix C, Collongues N, Bourre B, Laplaud D, Ayrignac X, Durand-Dubief F, Ruet A, Vukusic S, Marignier R, Dauchet L, Zephir H; NEMOS (Neuromyelitis Optica Study Group in Germany), NOMADMUS (Neuromyelitis Optica study Group in France), OFSEP (Observatoire Français de la Sclérose en Plaques) investigators. Giovannelli J, et al. Among authors: ayrignac x. Ann Clin Transl Neurol. 2021 Oct;8(10):2025-2037. doi: 10.1002/acn3.51451. Epub 2021 Sep 10. Ann Clin Transl Neurol. 2021. PMID: 34505407 Free PMC article.
Immune-mediated diseases involving central and peripheral nervous systems.
Leboyan A, Esselin F, Bascou AL, Duflos C, Ion I, Charif M, Castelnovo G, Carra-Dalliere C, Ayrignac X, Kerschen P, Chbicheb M, Nguyen L, Maria ATJ, Guilpain P, Carriere M, de Champfleur NM, Vincent T, Jentzer A, Labauge P, Devaux JJ, Taieb G. Leboyan A, et al. Among authors: ayrignac x. Eur J Neurol. 2023 Feb;30(2):490-500. doi: 10.1111/ene.15628. Epub 2022 Nov 27. Eur J Neurol. 2023. PMID: 36366904
Assessing the risk of multiple sclerosis disease-modifying therapies.
Ayrignac X, Bilodeau PA, Prat A, Girard M, Labauge P, Le Lorier J, Larochelle C, Duquette P. Ayrignac X, et al. Expert Rev Neurother. 2019 Jul;19(7):695-706. doi: 10.1080/14737175.2019.1627201. Epub 2019 Jun 26. Expert Rev Neurother. 2019. PMID: 31195842 Review.
POLR3-related disorder revealed by movement disorders.
Tailland M, Gonzalez V, Prin P, Carra-Dallière C, Ayrignac X, Labauge P. Tailland M, et al. Among authors: ayrignac x. Rev Neurol (Paris). 2021 Mar;177(3):328-330. doi: 10.1016/j.neurol.2020.06.013. Epub 2020 Sep 28. Rev Neurol (Paris). 2021. PMID: 33004219 No abstract available.
MRI characteristics of MOG-Ab associated disease in adults: An update.
Shor N, Deschamps R, Cobo Calvo A, Maillart E, Zephir H, Ciron J, Papeix C, Durand-Dubief F, Ruet A, Ayrignac X, Cohen M, Deiva K, Laplaud D, Bourre B, Audoin B, Collongues N, Vukusic S, Cotton F, Marignier R; NOMADMUS study group. Shor N, et al. Among authors: ayrignac x. Rev Neurol (Paris). 2021 Jan-Feb;177(1-2):39-50. doi: 10.1016/j.neurol.2020.06.016. Epub 2020 Oct 10. Rev Neurol (Paris). 2021. PMID: 33046261 Review.
134 results